Metraipolis › archive › dc_5b81ebc08cd3

Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12 — Europe PMC PMID:41156163

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41156163
DOI
10.3390/jcm14207293
License (as archived)
solo-consultazione
Archived
2026-11-09T06:58:49.579Z
SHA-256 of the archived text
88f418c39be966af1a53db8f18d6bf70519b343ed11b6e6704a37d2e7a599221
Stable URL of this page
https://metraipolis.com/documento/dc_5b81ebc08cd3

How to cite

Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12 — Europe PMC PMID:41156163 — Europe PMC (en), https://europepmc.org/article/MED/41156163 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5b81ebc08cd3 (Metraipolis archive dc_5b81ebc08cd3, sha256 88f418c39be966af1a53db8f18d6bf70519b343ed11b6e6704a37d2e7a599221)
BibTeX
@misc{dc5b81ebc08cd3,
  title = {Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12 — Europe PMC PMID:41156163},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41156163},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5b81ebc08cd3; sha256 88f418c39be966af1a53db8f18d6bf70519b343ed11b6e6704a37d2e7a599221},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41156163. Agents can read the archived copy with the MCP tool read_document.